About TissueNetix News TissueNetix Signs Exclusive License Agreement with Harvard for Muscular Thin Film (MTF) Technology to Enable Improved Drug Cardiotoxicity Screening TissueNetix elects Dr. Kevin Kit Parker, principal inventor of MTF, as scientific advisory board co-chair more news... Cellular N...

David Webb TissueNetix combines expertise in microfabrication, cellular biology and medical knowledge to develop next generation assays for drug screening and academic research. The goal of the company is to help scientists make better and quicker decisions based on cellular biology that accurately ...

Its All About the Network! News TissueNetix Signs Exclusive License Agreement with Harvard for Muscular Thin Film (MTF) Technology to Enable Improved Drug Cardiotoxicity Screening TissueNetix elects Dr. Kevin Kit Parker, principal inventor of MTF, as scientific advisory board co-chair more news... T...

Welcome to TissueNetix . read more... Contact TissueNetix If you have questions about the TissueNetix technology or want additional information about the company, please fill out the form to the right. Someone from TissueNetix will then contact you to supply you with the necessary information. Tissu...

David Giegel, PhD TissueNetix combines expertise in microfabrication, cellular biology and medical knowledge to develop next generation assays for drug screening and academic research. The goal of the company is to help scientists make better and quicker decisions based on cellular biology that accu...